US Stock MarketDetailed Quotes

BLRX BioLine Rx

Watchlist
  • 0.143
  • -0.017-10.88%
Close Jan 8 16:00 ET
  • 0.142
  • 0.000-0.21%
Post 19:59 ET
11.99MMarket Cap-0.48P/E (TTM)

BioLine Rx Key Stats

BioLine Rx Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 792.000K--
--2024/Q4-- / 7.718M--
Nov 25, 20242024/Q34.943M / 5.290M--
Aug 15, 20242024/Q25.393M / 2.940M--
May 28, 20242024/Q16.855M / 340.000K--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 792.000K--
--2024/Q4-- / 7.718M--
Nov 25, 20242024/Q34.943M / 5.290M--
Aug 15, 20242024/Q25.393M / 2.940M--
May 28, 20242024/Q16.855M / 340.000K--

Unlock Free Earnings Estimates

BioLine Rx Earnings Reports

Read more

Trending US Stocks
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Analysis

Analyst Rating

Updated: Jan 8, 2025

Buy

  • Buy

    100.00%
  • Hold

    0.00%
  • Sell

    0.00%

Price Target

No Data